title: Pains and Gains from China's Experiences with Emerging Epidemics: From SARS to H7N9.
abstract: Over the recent decades, China experienced several emerging virus outbreaks including those caused by the severe acute respiratory syndrome- (SARS-) coronavirus (Cov), H5N1 virus, and H7N9 virus. The SARS tragedy revealed faults in China's infectious disease prevention system, propelling the Chinese government to enact reforms that enabled better combating of the subsequent H1N1 and H7N9 avian flu epidemics. The system is buttressed by three fundamental, mutually reinforcing components: (1) enduring government administration reforms, including legislation establishing a unified public health emergency management system; (2) prioritized funding for biotechnology and biomedicine industrialization, especially in the areas of pathogen identification, drug production, and the development of vaccines and diagnostics; and (3) increasing investment for public health and establishment of a rapid-response infectious diseases prevention and control system. China is now using its hard-gained experience to support the fight against Ebola in Africa and the Middle East Respiratory Syndrome in its own country.
authors.affiliation: Department of Biochemistry and Molecular Biology, Health Science Center of Shenzhen University, Shenzhen 518060, China.
authors.forename: Pengfei
authors.identifier: 0000-0002-1315-6384
authors.initials: P
authors.lastname: Wei
authors.affiliation: Department of Biochemistry and Molecular Biology, Health Science Center of Shenzhen University, Shenzhen 518060, China.
authors.forename: Zelang
authors.identifier: 0000-0003-2450-6973
authors.initials: Z
authors.lastname: Cai
authors.affiliation: Department of Biochemistry and Molecular Biology, Health Science Center of Shenzhen University, Shenzhen 518060, China.
authors.forename: Jinwen
authors.initials: J
authors.lastname: Hua
authors.affiliation: Department of Biochemistry and Molecular Biology, Health Science Center of Shenzhen University, Shenzhen 518060, China.
authors.forename: Weijia
authors.initials: W
authors.lastname: Yu
authors.affiliation: Department of Biochemistry and Molecular Biology, Health Science Center of Shenzhen University, Shenzhen 518060, China.
authors.forename: Jiajie
authors.initials: J
authors.lastname: Chen
authors.affiliation: Department of Biochemistry and Molecular Biology, Health Science Center of Shenzhen University, Shenzhen 518060, China.
authors.forename: Kang
authors.initials: K
authors.lastname: Kang
authors.affiliation: Department of Biochemistry and Molecular Biology, Health Science Center of Shenzhen University, Shenzhen 518060, China.
authors.forename: Congling
authors.initials: C
authors.lastname: Qiu
authors.affiliation: Department of Biochemistry and Molecular Biology, Health Science Center of Shenzhen University, Shenzhen 518060, China.
authors.forename: Lanlan
authors.identifier: 0000-0003-2981-4932
authors.initials: L
authors.lastname: Ye
authors.affiliation: Department of Biochemistry and Molecular Biology, Health Science Center of Shenzhen University, Shenzhen 518060, China.
authors.forename: Jiayun
authors.identifier: 0000-0001-6508-7766
authors.initials: J
authors.lastname: Hu
authors.affiliation: Department of Biochemistry and Molecular Biology, Health Science Center of Shenzhen University, Shenzhen 518060, China.
authors.forename: Kunmei
authors.identifier: 0000-0002-5754-8697
authors.initials: K
authors.lastname: Ji
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D002675:Child, Preschool; D002681:China / Q000453:epidemiology; D003140:Communicable Disease Control / Q000379:methods / Q000592:standards; D021821:Communicable Diseases, Emerging / Q000401:mortality* / Q000517:prevention & control*; D058872:Epidemics / Q000517:prevention & control / Q000706:statistics & numerical data; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007251:Influenza, Human / Q000401:mortality* / Q000517:prevention & control*; D008297:Male; D008875:Middle Aged; D011159:Population Surveillance / Q000379:methods; D015995:Prevalence; D012307:Risk Factors; D045169:Severe Acute Respiratory Syndrome / Q000401:mortality* / Q000517:prevention & control*; D015996:Survival Rate; D055815:Young Adult